Why Harrow stock is back in focus after its latest results Harrow (HROW) has been in the spotlight after Q4 2025 results combined strong revenue growth with an earnings miss, a back end loaded 2026 ...
Investors considering a purchase of Harrow Inc (Symbol: HROW) stock, but tentative about paying the going market price of $35.48/share, might benefit from considering selling puts among the ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2024. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results